K931366

Substantially Equivalent

TRI-POINT LIQUIMMUNE IMMUONASSAY CONTROL, L-1,2,3

Applicant: Medical Analysis Systems, Inc.
Product code: JJY
Advisory panel: Clinical Chemistry
Date received: 1993-03-17
Decision date: 1993-07-28
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Camarillo, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.